How have GTH shares performed in 2024?

Genetron's stock was trading at $3.68 at the beginning of 2024. Since then, GTH stock has increased by 9.5% and is now trading at $4.03. View the best growth stocks for 2024 here .

When is Genetron's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our GTH earnings forecast .

How were Genetron's earnings last quarter?

Genetron Holdings Limited (NASDAQ:GTH) posted its quarterly earnings data on Sunday, May, 23rd. The company reported ($0.51) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by $0.30. The business earned $14.05 million during the quarter. Read the conference call transcript .

When did Genetron's stock split?

Genetron shares reverse split on Thursday, October 26th 2023. The 1-3 reverse split was announced on Thursday, October 26th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

When did Genetron IPO?

Genetron (GTH) raised $162 million in an IPO on Friday, June 19th 2020. The company issued 13,000,000 shares at a price of $11.50-$13.50 per share. Credit Suisse and CICC acted as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers.

How do I buy shares of Genetron?

Shares of GTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:GTH

Genetron (GTH) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free GTH Stock Alerts

$4.03

+0.01 (+0.25%)

(As of 03/28/2024)

Compare

Today's Range: $4.02
▼
$4.05
50-Day Range: $3.79
▼
$4.03
52-Week Range: $2.08
▼
$4.05

Volume: 412,600 shs
Average Volume: 51,662 shs
Market Capitalization: $127.43 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Headlines Ownership SEC Filings Short Interest Social Media

Get Genetron alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Genetron Stock (NASDAQ:GTH)

Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.

GTH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GTH Stock News Headlines

March 29, 2024 | finanznachrichten.de

Genetron Holdings Limited: Genetron Health Announces Completion of Going Private Transaction

March 28, 2024 | globenewswire.com

Genetron Health Announces Completion of Going Private Transaction

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 21, 2024 | finanznachrichten.de

Genetron Holdings Limited: Genetron Health Announces Shareholders' Approval of Merger Agreement

February 21, 2024 | finance.yahoo.com

Genetron Health Announces Shareholders’ Approval of Merger Agreement

February 21, 2024 | globenewswire.com

Genetron Health Announces Shareholders' Approval of Merger Agreement

February 14, 2024 | fool.com

Genetron (NASDAQ: GTH)

February 14, 2024 | wsj.com

Genetron Holdings Ltd. ADR

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

January 17, 2024 | finance.yahoo.com

Genetron Health to Hold Extraordinary General Meeting of Shareholders

January 9, 2024 | seekingalpha.com

Albertsons-Kroger And 15 Other Merger Arbitrage Opportunities With Wide Spreads

January 9, 2024 | seekingalpha.com

Genetron Holdings' Enticing Arbitrage Return

November 24, 2023 | morningstar.com

Genetron Holdings Ltd ADR GTH

October 12, 2023 | finanznachrichten.de

Genetron Holdings Limited: Genetron Health Enters into Definitive Merger Agreement for Going Private Transaction

October 12, 2023 | msn.com

Stocks Rise Before the Open as U.S. Inflation Data Looms

October 12, 2023 | msn.com

Stocks Climb Before the Open as Bond Yields Fall, U.S. Inflation Data Looms

October 11, 2023 | finance.yahoo.com

Genetron Health Enters into Definitive Merger Agreement for Going Private Transaction

May 24, 2023 | msn.com

Genetron Health receives Nasdaq notice for non-compliance

March 27, 2023 | msn.com

American Depositary Receipts of Asian Stocks Lower Amid Banking Sector Worries

January 18, 2023 | finance.yahoo.com

Genetron Health Regains Compliance With Nasdaq Minimum Bid Price Requirement

December 28, 2022 | msn.com

Earlier US Stock Market Losses Weighed on Asian Equities

November 7, 2022 | finance.yahoo.com

Genetron Health Announces Receipt of Notification from Nasdaq

October 19, 2022 | seekingalpha.com

GTH Genetron Holdings Limited

October 12, 2022 | finance.yahoo.com

Genetron Health Reports Unaudited Second Quarter 2022 Financial Results

September 20, 2022 | reuters.com

Genetron Holdings Ltd

September 2, 2022 | finance.yahoo.com

Genetron Health Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

August 22, 2022 | benzinga.com

Genetron Health Announces Receipt of a...

See More Headlines

Receive GTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/23/2021
Today: 4/18/2024
Next Earnings (Estimated): 5/10/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: NASDAQ:GTH
CUSIP: N/A
CIK: 1782594
Web: www.genetronhealth.com
Phone: 86-10-5090-7500
Fax: N/A
Employees: 993
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $94.34 million
Price / Sales: 1.35
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.63 per share
Price / Book: 1.53

Miscellaneous

Outstanding Shares: 31,620,000
Free Float: N/A
Market Cap: $127.43 million
Optionable: Not Optionable
Beta: 0.51

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Sizhen Wang (Age 47)
Co-Founder, CEO & Chairman
Dr. Wei-Wu He Ph.D. (Age 59)
Co-Founder & Chairman Emeritus
Dr. Hai Yan M.D. (Age 56)
Ph.D., Co-Founder, Chief Scientific Officer & Director
Mr. Ce Xu (Age 42)
Chief Financial Officer
Ms. Victoria Lei
Chief Operating Officer
Dr. Yuchen Jiao M.D. (Age 46)
Ph.D., Chief Technology Officer
Mr. Yong Liang (Age 50)
Chief Human Resources Officer
Dr. Yun-Fu Hu Ph.D. (Age 61)
Chief Medical Officer
Ms. Lily Liu
Chief Commercial Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

GTH Stock Analysis - Frequently Asked Questions

How have GTH shares performed in 2024?: Genetron's stock was trading at $3.68 at the beginning of 2024. Since then, GTH stock has increased by 9.5% and is now trading at $4.03.
View the best growth stocks for 2024 here.
When is Genetron's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our GTH earnings forecast.
How were Genetron's earnings last quarter?: Genetron Holdings Limited (NASDAQ:GTH) posted its quarterly earnings data on Sunday, May, 23rd. The company reported ($0.51) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by $0.30. The business earned $14.05 million during the quarter.
Read the conference call transcript.
When did Genetron's stock split?: Genetron shares reverse split on Thursday, October 26th 2023. The 1-3 reverse split was announced on Thursday, October 26th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

When did Genetron IPO?: Genetron (GTH) raised $162 million in an IPO on Friday, June 19th 2020. The company issued 13,000,000 shares at a price of $11.50-$13.50 per share. Credit Suisse and CICC acted as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers.
How do I buy shares of Genetron?: Shares of GTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GTH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Genetron (GTH) Stock Price, News & Analysis

About Genetron Stock (NASDAQ:GTH)

GTH Stock Price History

GTH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

GTH Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info